Palo Alto Investors

Latest statistics and disclosures from Palo Alto Investors's latest quarterly 13F-HR filing:

Palo Alto Investors portfolio companies for December 2013 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
CYBX Cyberonics 11.91 1951581 65.42 62.02
UTHR United Therapeutics Corporation 11.56 +3.00% 1095428 113.08 96.20
AUXL Auxilium Pharmaceuticals 9.44 +7.00% 4883879 20.73 25.97
CBST Cubist Pharmaceuticals 8.58 +31.00% 1336136 68.87 63.95
ABMD ABIOMED 6.70 2687347 26.74 24.64
ITMN InterMune 5.25 +6.00% 3819606 14.73 28.29
QCOR Questcor Pharmaceuticals 4.90 +46.00% 963995 54.45 76.95
BMRN BioMarin Pharmaceutical 4.86 +31.00% 741087 70.35 60.89
STAA STAAR Surgical Company 4.85 3214253 16.19 17.50
AMAG AMAG Pharmaceuticals 3.99 +2.00% 1761332 24.28 17.88
VNDA Vanda Pharmaceuticals 3.75 +11.00% 3238624 12.41 13.58
Kythera Biopharmaceuticals I 3.14 +182.00% 900559 37.35 0.00
Anacor Pharmaceuticals In 2.51 1603278 16.78 0.00
ARIA Ariad Pharmaceuticals 2.19 NEW 3441324 6.82 7.20
SQNM Sequenom 2.05 +14.00% 9394627 2.34 2.59
MNTA Momenta Pharmaceuticals 1.91 1157276 17.68 11.10
ALIM Alimera Sciences 1.59 3634984 4.70 6.31
RIGL Rigel Pharmaceuticals 1.39 -17.00% 5217001 2.85 3.20
VPHM ViroPharma Incorporated 1.35 -90.00% 290916 49.85 49.96
Prothena 1.33 +507.00% 537418 26.52 0.00
NPSP NPS Pharmaceuticals 1.24 NEW 439100 30.36 24.55
Qlt 1.07 2053311 5.57 0.00
Clovis Oncology 1.05 NEW 186900 60.27 0.00
FOLD Amicus Therapeutics 0.88 -13.00% 4008576 2.35 1.84
EXAS EXACT Sciences Corporation 0.86 785776 11.75 12.84
Insmed 0.46 +9.00% 292199 17.00 0.00
SPPI Spectrum Pharmaceuticals 0.33 402285 8.85 6.74
AVEO AVEO Pharmaceuticals 0.24 -59.00% 1429174 1.83 1.34
XOMA CORP Common equity shares 0.16 -38.00% 256100 6.73 0.00
Cytokinetics 0.14 NEW 232808 6.50 0.00
Hyperion Therapeutics 0.12 62700 20.22 0.00
Sophiris Bio 0.10 +432.00% 292900 3.70 0.00
CELG Celgene Corporation 0.04 +53.00% 2590 169.11 141.51
Align Technology 0.04 +53.00% 7788 57.14 0.00

Past 13F-HR SEC Filings for Palo Alto Investors

View All Filings for Palo Alto Investors